News
![Customers Bancorp Listed in Kiplinger’s 6 Best Financial Stocks to Buy in 2021: https://mms.businesswire.com/media/20200311005404/en/779090/5/Bancorp_Logo.jpg](https://www.sharewise.com/rails/active_storage/representations/eyJfcmFpbHMiOnsibWVzc2FnZSI6IkJBaHBBNVNwS0E9PSIsImV4cCI6bnVsbCwicHVyIjoiYmxvYl9pZCJ9fQ==--9e5a14af64fef42ad5c02082eb75186aec9283b0/eyJfcmFpbHMiOnsibWVzc2FnZSI6IkJBaDdCam9MY21WemFYcGxTU0lKTXpVd2VBWTZCa1ZVIiwiZXhwIjpudWxsLCJwdXIiOiJ2YXJpYXRpb24ifX0=--aa36f503a05c343bf077379e5dc8bce118d9db18/Bancorp_Logo.jpg?locale=us)
Customers Bancorp Listed in Kiplinger’s 6 Best Financial Stocks to Buy in 2021
Customers Bancorp (NYSE:CUBI) was recently identified as one of the “best financial stocks to buy” in 2021 by Kiplinger. The publication looked at the financial sector, one of the hardest-hit
![Connection (CNXN) Announces a Special Dividend to Shareholders: https://mms.businesswire.com/media/20200512005920/en/791247/5/Connection_Corp_logo_tall_4c_highres.jpg](https://www.sharewise.com/rails/active_storage/representations/eyJfcmFpbHMiOnsibWVzc2FnZSI6IkJBaHBBNmdETlE9PSIsImV4cCI6bnVsbCwicHVyIjoiYmxvYl9pZCJ9fQ==--09ff82277de113be309aa0592edfadcad9ac34b0/eyJfcmFpbHMiOnsibWVzc2FnZSI6IkJBaDdCam9MY21WemFYcGxTU0lKTXpVd2VBWTZCa1ZVIiwiZXhwIjpudWxsLCJwdXIiOiJ2YXJpYXRpb24ifX0=--aa36f503a05c343bf077379e5dc8bce118d9db18/Connection_Corp_logo_tall_4c_highres.jpg?locale=us)
Connection (CNXN) Announces a Special Dividend to Shareholders
Connection (PC Connection, Inc.; NASDAQ: CNXN), a leading information technology solutions provider to business, government, and education markets, today announced that its Board of Directors
![Koch Real Estate Investments Makes $32 Million Long-Term Investment in Ladder Capital Corp: https://mms.businesswire.com/media/20191205005702/en/623488/5/LCAM_logo_%28rgb%29.jpg](https://www.sharewise.com/rails/active_storage/representations/eyJfcmFpbHMiOnsibWVzc2FnZSI6IkJBaHBBM2VyRlE9PSIsImV4cCI6bnVsbCwicHVyIjoiYmxvYl9pZCJ9fQ==--6b47206c854820336da75dca47361f31bf7215ba/eyJfcmFpbHMiOnsibWVzc2FnZSI6IkJBaDdCam9MY21WemFYcGxTU0lKTXpVd2VBWTZCa1ZVIiwiZXhwIjpudWxsLCJwdXIiOiJ2YXJpYXRpb24ifX0=--aa36f503a05c343bf077379e5dc8bce118d9db18/LCAM_logo_-28rgb-29.jpg?locale=us)
Koch Real Estate Investments Makes $32 Million Long-Term Investment in Ladder Capital Corp
Ladder Capital Corp (“Ladder” or the “Company”) (NYSE: LADR) announced that an affiliate of Koch Real Estate Investments, LLC exercised its option to invest $32 million in Ladder’s common equity
![Alcoa Schedules Fourth Quarter and Full Year 2020 Earnings Release and Conference Call: https://mms.businesswire.com/media/20191121005110/en/566032/5/Alcoa_logo_horizontal_blue_%282%29.jpg](https://www.sharewise.com/rails/active_storage/representations/eyJfcmFpbHMiOnsibWVzc2FnZSI6IkJBaHBBNXlrRWc9PSIsImV4cCI6bnVsbCwicHVyIjoiYmxvYl9pZCJ9fQ==--aaf6432637de856c3fef8280f7a36a58e26d954f/eyJfcmFpbHMiOnsibWVzc2FnZSI6IkJBaDdCam9MY21WemFYcGxTU0lKTXpVd2VBWTZCa1ZVIiwiZXhwIjpudWxsLCJwdXIiOiJ2YXJpYXRpb24ifX0=--aa36f503a05c343bf077379e5dc8bce118d9db18/Alcoa_logo_horizontal_blue_-282-29.jpg?locale=us)
Alcoa Schedules Fourth Quarter and Full Year 2020 Earnings Release and Conference Call
Alcoa Corporation plans to announce its fourth quarter and full year 2020 financial results on Wednesday, January 20, 2021 after the close of trading on the New York Stock Exchange.
The press
![NOXXON Announces Initiation of NOX-A12 Manufacturing for Future Clinical Studies](/assets/news/news2-a19c21d90ec8043c932052617f43da76ea8e48ecd096318e237ea24d69a5c8b8.png)
NOXXON Announces Initiation of NOX-A12 Manufacturing for Future Clinical Studies
Regulatory News:
NOXXON Pharma N.V. (Euronext Growth Paris: ALNOX) (Paris:ALNOX), a biotechnology company focused on improving cancer treatments by targeting the tumor microenvironment (TME)
![What Is Time Value of Money?](/assets/news/news3-3816cd3656012f9a06bae00ff06108b383643da017a8247fff474f84ea8a7c5a.png)
What Is Time Value of Money?
What Is Time Value of Money? was originally published here.
if (typeof jQuery == 'undefined') { document.write('<scr' + 'ipt type="text/javascript"![Pfizer and BioNTech to Supply the European Union with 100 Million Additional Doses of COMIRNATY®http://www.flickr.com/photos/w0ahitslo/6955091156/sizes/z/in/photostream/: All rights reserved by Queen Beuaroo](https://www.sharewise.com/rails/active_storage/representations/eyJfcmFpbHMiOnsibWVzc2FnZSI6IkJBaHBBZHc9IiwiZXhwIjpudWxsLCJwdXIiOiJibG9iX2lkIn19--be1a2af5756eaa0acf5414ead3504a7e3ad45f8a/eyJfcmFpbHMiOnsibWVzc2FnZSI6IkJBaDdCam9MY21WemFYcGxTU0lKTXpVd2VBWTZCa1ZVIiwiZXhwIjpudWxsLCJwdXIiOiJ2YXJpYXRpb24ifX0=--aa36f503a05c343bf077379e5dc8bce118d9db18/Pfizer.jpg?locale=us)
Pfizer and BioNTech to Supply the European Union with 100 Million Additional Doses of COMIRNATY®
Pfizer Inc. (NYSE: PFE) and BioNTech SE (Nasdaq: BNTX) today announced they will supply an additional 100 million doses of COMIRNATY®, the companies’ COVID-19 Vaccine, to the 27 European Union (EU)
![Ennis Will Acquire Assets of Infoseal: https://mms.businesswire.com/media/20191220005069/en/421489/5/EnnisLogo.jpg](https://www.sharewise.com/rails/active_storage/representations/eyJfcmFpbHMiOnsibWVzc2FnZSI6IkJBaHBBK1NsR0E9PSIsImV4cCI6bnVsbCwicHVyIjoiYmxvYl9pZCJ9fQ==--4db833b142ad5488899bfe788eb54d1942696e47/eyJfcmFpbHMiOnsibWVzc2FnZSI6IkJBaDdCam9MY21WemFYcGxTU0lKTXpVd2VBWTZCa1ZVIiwiZXhwIjpudWxsLCJwdXIiOiJ2YXJpYXRpb24ifX0=--aa36f503a05c343bf077379e5dc8bce118d9db18/EnnisLogo.jpg?locale=us)
Ennis Will Acquire Assets of Infoseal
Ennis, Inc. (the “Company"), (NYSE: EBF), today announced that one of its wholly owned subsidiaries has entered into a Letter of Intent to acquire the assets and assume some liabilities of Infoseal
![Insight Awarded Global SASE Partner of the Year from Palo Alto Networks: https://mms.businesswire.com/media/20191108005290/en/699137/5/Insight_Logo__Med.jpg](https://www.sharewise.com/rails/active_storage/representations/eyJfcmFpbHMiOnsibWVzc2FnZSI6IkJBaHBBM29rRUE9PSIsImV4cCI6bnVsbCwicHVyIjoiYmxvYl9pZCJ9fQ==--e6fab02a2aea738283cfec9df328bd6044f772cb/eyJfcmFpbHMiOnsibWVzc2FnZSI6IkJBaDdCam9MY21WemFYcGxTU0lKTXpVd2VBWTZCa1ZVIiwiZXhwIjpudWxsLCJwdXIiOiJ2YXJpYXRpb24ifX0=--aa36f503a05c343bf077379e5dc8bce118d9db18/Insight_Logo__Med.jpg?locale=us)
Insight Awarded Global SASE Partner of the Year from Palo Alto Networks
Insight Enterprises (NASDAQ: NSIT), the global integrator of Insight Intelligent Technology Solutions™ for organizations of all sizes, was named Palo Alto Networks Global SASE Partner of the Year.
Pitney Bowes Announces Pricing Update for Delivery Services as Parcel Volumes Continue to Surge into 2021
Pitney Bowes Inc. (NYSE:PBI), a global technology company that provides commerce solutions in the areas of ecommerce, shipping, mailing and financial services, today announced that pricing
![Angelika Anywhere: Curated for Film Lovers](/assets/news/news5-af8c677c86bb4b693f58afef33877e6f798ff0d7e2b4fa69b6e89960549b5ee6.png)
Angelika Anywhere: Curated for Film Lovers
Reading International, Inc. (NASDAQ: RDI) announces the launch of Angelika Anywhere, a streaming platform curated for film lovers, as inspired by its Angelika Film Center in New York City, North
![Clovis Oncology Submits Investigational New Drug Applications for Novel Peptide-Targeted Radionuclide FAP-2286 for Therapeutic and Imaging Clinical Trial: https://mms.businesswire.com/media/20191107005162/en/305545/5/Clovis_Logo_Process_Color.jpg](https://www.sharewise.com/rails/active_storage/representations/eyJfcmFpbHMiOnsibWVzc2FnZSI6IkJBaHBBOTRqRUE9PSIsImV4cCI6bnVsbCwicHVyIjoiYmxvYl9pZCJ9fQ==--8c255f1cb7b73806f677f1d1d64e93866d2979a5/eyJfcmFpbHMiOnsibWVzc2FnZSI6IkJBaDdCam9MY21WemFYcGxTU0lKTXpVd2VBWTZCa1ZVIiwiZXhwIjpudWxsLCJwdXIiOiJ2YXJpYXRpb24ifX0=--aa36f503a05c343bf077379e5dc8bce118d9db18/Clovis_Logo_Process_Color.jpg?locale=us)
Clovis Oncology Submits Investigational New Drug Applications for Novel Peptide-Targeted Radionuclide FAP-2286 for Therapeutic and Imaging Clinical Trial
Clovis Oncology, Inc. (NASDAQ: CLVS) today announced that the company has completed submission of two Investigational New Drug (IND) applications to the U.S. Food and Drug Administration (FDA) for
![NCR is Global Leader in Restaurant POS Software According to Research and Consulting Firm RBR](/assets/news/news3-3816cd3656012f9a06bae00ff06108b383643da017a8247fff474f84ea8a7c5a.png)
NCR is Global Leader in Restaurant POS Software According to Research and Consulting Firm RBR
NCR Corporation (NYSE: NCR) leads the global restaurant point-of-sale (POS) software market according to research and consulting firm RBR. The Global POS Software 2020 Report conducted by RBR
![Eyenovia Submits New Drug Application to FDA for Pharmacologic Mydriasis with MydCombi Targeting 80 Million Patient Encounters in the U.S. Annually](/assets/news/news6-ad07925a95156ae03dbe17caf44a9dc29f254ff2c2a42c7678d35288ad55cec8.png)
Eyenovia Submits New Drug Application to FDA for Pharmacologic Mydriasis with MydCombi Targeting 80 Million Patient Encounters in the U.S. Annually
Eyenovia, Inc. (NASDAQ: EYEN), a clinical stage ophthalmic biopharmaceutical company with Phase 3 programs in presbyopia, myopia and mydriasis, today announced that it has submitted a New Drug
![Essex Property Trust Announces Executive Leadership Succession: https://mms.businesswire.com/media/20191108005660/en/625771/5/Essex_Logo_Black_%28002%29.jpg](https://www.sharewise.com/rails/active_storage/representations/eyJfcmFpbHMiOnsibWVzc2FnZSI6IkJBaHBBK000RUE9PSIsImV4cCI6bnVsbCwicHVyIjoiYmxvYl9pZCJ9fQ==--8ac7bfe485aea5b16eaa27ea6770ab98462dab33/eyJfcmFpbHMiOnsibWVzc2FnZSI6IkJBaDdCam9MY21WemFYcGxTU0lKTXpVd2VBWTZCa1ZVIiwiZXhwIjpudWxsLCJwdXIiOiJ2YXJpYXRpb24ifX0=--aa36f503a05c343bf077379e5dc8bce118d9db18/Essex_Logo_Black_-28002-29.jpg?locale=us)
Essex Property Trust Announces Executive Leadership Succession
Essex Property Trust, Inc. (NYSE:ESS) announced today the planned succession for the Chief Operating Officer (COO) and the Chief Financial Officer (CFO).
John Burkart will retire as the Company’s
![LORBRENA® (lorlatinib) sNDA in Previously Untreated ALK-Positive Lung Cancer Accepted for Priority Review by U.S. FDAhttp://www.flickr.com/photos/w0ahitslo/6955091156/sizes/z/in/photostream/: All rights reserved by Queen Beuaroo](https://www.sharewise.com/rails/active_storage/representations/eyJfcmFpbHMiOnsibWVzc2FnZSI6IkJBaHBBZHc9IiwiZXhwIjpudWxsLCJwdXIiOiJibG9iX2lkIn19--be1a2af5756eaa0acf5414ead3504a7e3ad45f8a/eyJfcmFpbHMiOnsibWVzc2FnZSI6IkJBaDdCam9MY21WemFYcGxTU0lKTXpVd2VBWTZCa1ZVIiwiZXhwIjpudWxsLCJwdXIiOiJ2YXJpYXRpb24ifX0=--aa36f503a05c343bf077379e5dc8bce118d9db18/Pfizer.jpg?locale=us)
LORBRENA® (lorlatinib) sNDA in Previously Untreated ALK-Positive Lung Cancer Accepted for Priority Review by U.S. FDA
Pfizer Inc. (NYSE:PFE) today announced that the U.S. Food and Drug Administration (FDA) has accepted for Priority Review the supplemental New Drug Application (sNDA) for LORBRENA ® (lorlatinib) as
![US Foods to Participate in the ICR Virtual Conference on Jan. 11, 2021: https://mms.businesswire.com/media/20191107005203/en/650770/5/USF_LOGOWITHOUTTAG_RGB_WEB.jpg](https://www.sharewise.com/rails/active_storage/representations/eyJfcmFpbHMiOnsibWVzc2FnZSI6IkJBaHBBeEVqRUE9PSIsImV4cCI6bnVsbCwicHVyIjoiYmxvYl9pZCJ9fQ==--b3a951f3d3733dc9ca6392c07ce1ec04f2a28e35/eyJfcmFpbHMiOnsibWVzc2FnZSI6IkJBaDdCam9MY21WemFYcGxTU0lKTXpVd2VBWTZCa1ZVIiwiZXhwIjpudWxsLCJwdXIiOiJ2YXJpYXRpb24ifX0=--aa36f503a05c343bf077379e5dc8bce118d9db18/USF_LOGOWITHOUTTAG_RGB_WEB.jpg?locale=us)
US Foods to Participate in the ICR Virtual Conference on Jan. 11, 2021
US Foods Holding Corp. (NYSE: USFD) Chairman and Chief Executive Officer, Pietro Satriano, and Chief Financial Officer, Dirk Locascio, will present at the ICR Conference on Monday, Jan. 11 at 1:30
![Eurofins Genomics Launches Cost-Effective SARS-CoV-2 full-length Viral Genome Sequencing Services Essential in the Identification of Viral Mutations: https://mms.businesswire.com/media/20200421005718/en/318625/5/EUROFINS_jpg.jpg](https://www.sharewise.com/rails/active_storage/representations/eyJfcmFpbHMiOnsibWVzc2FnZSI6IkJBaHBBdzNhTUE9PSIsImV4cCI6bnVsbCwicHVyIjoiYmxvYl9pZCJ9fQ==--39aa1a81526ac2a70cd04ea71d1ab318c23b607c/eyJfcmFpbHMiOnsibWVzc2FnZSI6IkJBaDdCam9MY21WemFYcGxTU0lKTXpVd2VBWTZCa1ZVIiwiZXhwIjpudWxsLCJwdXIiOiJ2YXJpYXRpb24ifX0=--aa36f503a05c343bf077379e5dc8bce118d9db18/EUROFINS_.jpg?locale=us)
Eurofins Genomics Launches Cost-Effective SARS-CoV-2 full-length Viral Genome Sequencing Services Essential in the Identification of Viral Mutations
Eurofins Genomics (Paris:ERF) launches an optimised, cost-effective, SARS-CoV-2, next-generation sequencing service providing full length viral genome sequences. The best-in-class ARTIC NGS Oligo
![PRISMAFLEX INTERNATIONAL : Evolution in the capital standing for Anthem Displays](/assets/news/news3-3816cd3656012f9a06bae00ff06108b383643da017a8247fff474f84ea8a7c5a.png)
PRISMAFLEX INTERNATIONAL : Evolution in the capital standing for Anthem Displays
Prismaflex partner up with Circle Graphics and maintain a minority holding via their Prismaflex USA subsidiary of 28.91%.
Prismaflex International announce they have concluded an association
![THERANEXUS ANNOUNCES ITS FINANCIAL CALENDAR FOR 2021](/assets/news/news4-fce0efe65d8ba787508ef718c0a20bed51e468dbc656c188c43e13f15b4a4f53.png)
THERANEXUS ANNOUNCES ITS FINANCIAL CALENDAR FOR 2021
Lyon, December 28, 2020 – Theranexus, a biopharmaceutical company innovating in the treatment of neurological diseases and pioneer in the development of drug candidates modulating the interaction
![Polaris Schedules Fourth Quarter and Full Year 2020 Earnings Call and Webcast: https://mms.businesswire.com/media/20191223005031/en/764313/5/600x100_polaris_black_logo.jpg](https://www.sharewise.com/rails/active_storage/representations/eyJfcmFpbHMiOnsibWVzc2FnZSI6IkJBaHBBMWhJR1E9PSIsImV4cCI6bnVsbCwicHVyIjoiYmxvYl9pZCJ9fQ==--b8ce01393d2f7d0c3eb3f1227b00fca638e3818a/eyJfcmFpbHMiOnsibWVzc2FnZSI6IkJBaDdCam9MY21WemFYcGxTU0lKTXpVd2VBWTZCa1ZVIiwiZXhwIjpudWxsLCJwdXIiOiJ2YXJpYXRpb24ifX0=--aa36f503a05c343bf077379e5dc8bce118d9db18/600x100_polaris_black_logo.jpg?locale=us)
Polaris Schedules Fourth Quarter and Full Year 2020 Earnings Call and Webcast
Polaris Inc. (NYSE: PII) announced today that it will release its fourth quarter and full year 2020 financial results on Tuesday, January 26, 2021, and will hold a conference call and webcast at
![Customers Bank Wins Prestigious Global Everbridge Critical Event Management Impact Award: https://mms.businesswire.com/media/20200311005404/en/779090/5/Bancorp_Logo.jpg](https://www.sharewise.com/rails/active_storage/representations/eyJfcmFpbHMiOnsibWVzc2FnZSI6IkJBaHBBNVNwS0E9PSIsImV4cCI6bnVsbCwicHVyIjoiYmxvYl9pZCJ9fQ==--9e5a14af64fef42ad5c02082eb75186aec9283b0/eyJfcmFpbHMiOnsibWVzc2FnZSI6IkJBaDdCam9MY21WemFYcGxTU0lKTXpVd2VBWTZCa1ZVIiwiZXhwIjpudWxsLCJwdXIiOiJ2YXJpYXRpb24ifX0=--aa36f503a05c343bf077379e5dc8bce118d9db18/Bancorp_Logo.jpg?locale=us)
Customers Bank Wins Prestigious Global Everbridge Critical Event Management Impact Award
Customers Bank was selected as the winner of the highly coveted 2020 Best Example of Making an Impact on Business Award presented by Everbridge, an organization focused on life-saving efforts
![Foresight Autonomous Holdings Prices $26 Million Registered Direct Offering](/assets/news/news8-29d1d55c755b03e328399113b5bdd004223f995e95194ba5ee80af9da39a41e3.png)
Foresight Autonomous Holdings Prices $26 Million Registered Direct Offering
Foresight Autonomous Holdings Ltd. (Nasdaq and TASE: FRSX) (“Foresight” or the “Company”), today announced it has entered into definitive agreements with investors for the purchase and sale of
![Lineage Cell Therapeutics Provides End of Year Shareholder Letter : https://mms.businesswire.com/media/20191210005404/en/737852/5/LINEAGE_SCREEN_JPEG_1800x360.jpg](https://www.sharewise.com/rails/active_storage/representations/eyJfcmFpbHMiOnsibWVzc2FnZSI6IkJBaHBBNDJtRmc9PSIsImV4cCI6bnVsbCwicHVyIjoiYmxvYl9pZCJ9fQ==--72b88093378d3ac7af38e94191d21fae0c1daae8/eyJfcmFpbHMiOnsibWVzc2FnZSI6IkJBaDdCam9MY21WemFYcGxTU0lKTXpVd2VBWTZCa1ZVIiwiZXhwIjpudWxsLCJwdXIiOiJ2YXJpYXRpb24ifX0=--aa36f503a05c343bf077379e5dc8bce118d9db18/LINEAGE_SCREEN_JPEG_1800x360.jpg?locale=us)
Lineage Cell Therapeutics Provides End of Year Shareholder Letter
Lineage Cell Therapeutics, Inc. (NYSE American and TASE: LCTX), a clinical-stage biotechnology company developing allogeneic cell therapies for unmet medical needs, today provided a year-end review
![Congress Extends Critical Legislation Enabling Employers to Enhance Financial Wellness Programs](/assets/news/news16-82a218458f0e15ae617f9186b258dfd3add112716106c6ee3cbb48563ccdef52.png)
Congress Extends Critical Legislation Enabling Employers to Enhance Financial Wellness Programs
Gradifi by E*TRADE, a student loan payment benefit administrator, today applauded Congress’ decision to extend critical legislation that preserves for five years the tax-free status of